Ravenquest Biomed Inc. appointed George Robinson as Chief Executive Officer and a director of the Company, David Cross as Chief Financial Officer, and Marla K. Ritchie as Corporate Secretary. The company announced that resignation of Anton J. Drescher as President and Chief Executive Officer, but will remain on the company's board of directors.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -.--% | -.--% | -.--% |
2020 | RavenQuest BioMed Inc. announced that it has received CAD 0.480718 million in funding | CI |
2020 | RavenQuest BioMed Inc. announced that it expects to receive CAD 1 million in funding | CI |
1st Jan change | Capi. | |
---|---|---|
-.--% | 182 | |
+9.73% | 7.61B | |
-35.16% | 3.09B | |
+5.01% | 2.63B | |
-5.08% | 1.5B | |
-15.76% | 1.01B | |
+15.96% | 761M | |
-13.03% | 669M | |
-2.68% | 611M | |
-16.44% | 592M |
- Stock Market
- Equities
- RVVQF Stock
- News RavenQuest BioMed Inc.
- Ravenquest Biomed Inc Announces Management Changes